You are cordially invited to the Molecular Medicine Research Institute’s Open House and Life Science Entrepreneurs Summer Wine & Jazz Event. Sponsered by Morgan Lewis and CMC Travel Services, inc.

Tour MMRI’s state of the art laboratory facilities, and learn about the wide array of services and certifications, which make MMRI the best choice for new life science start- ups.

In the 14 years since its creation, the MMRI Accelerator has over a 90% success rate for new Life Science Ventures including Chemocentryx, Alvine Pharmaceuticals, Raven Biotechnologies, Juvaris, Abmaxis and Threshold Pharmaceuticals.

Meet the companies currently at the MMRI Accelerator, and learn about their cutting edge approaches to developing new therapeutic drugs, methods, materials, and devices. Learn about the non-profit research conducted at MMRI. Meet our sponsors to find out how they can help you with your current or next venture.

Merck Pharmaceuticals announced today that they had acquired Abmaxis cCorporation, an MMRI graduate affiliate company.

JUVARIS ANNOUNCES RECEIVING NIH GRANT AWARD FOR HIV VACCINE DEVELOPMENT

Pleasanton, CA – March 7, 2006 – Juvaris BioTherapeutics Inc. today announced the award of an 18-month Small Business Innovation Research (SBIR)-Advanced Technology grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for the testing of a novel vaccine ultimately directed against Human Immunodeficiency Virus (HIV), the causative agent for Acquired Immunodeficiency Disease Syndrome (AIDS) in humans.